The study examined the potential roles of high blood cholesterol and the cholesterol metabolite 27-hydroxycholesterol (an endogenous selective estrogen receptor antagonist) in increasing the risk of coronary heart disease caused by menopausal hormone therapy. The findings indicate that higher levels of low-density lipoprotein cholesterol, but not 27-hydroxycholesterol, were related to risk of coronary heart disease and that low-density lipoprotein cholesterol, but not 27-hydroxycholesterol, further increased the risk of coronary heart disease in women exposed to menopausal hormone therapy. The risk of coronary heart disease resulting from menopausal hormone therapy begins to increase at a low-density lipoprotein cholesterol level of Ϸ3.36 mmol/L (130 mg/dL). Screening women for low-density lipoprotein cholesterol levels could be helpful in making a decision about whether to recommend menopausal hormone therapy. See p 1577.
Predictors of Early and Late Enrollment in Cardiac Rehabilitation, Among Those Referred, After Acute Myocardial Infarction
Cardiac rehabilitation (CR) is a key component of the comprehensive care of acute myocardial infarction (AMI) patients and is a Class I recommendation after AMI. While improving the use of CR has been a longstanding goal for quality improvement, there remains a gap between referral to CR and subsequent participation. In our study, despite a high CR referral rate of 66% post-AMI, only 29% referred patients participated in CR at 1-month and less than half participated at 6-months after AMI, making it an important quality improvement target. Several patient-oriented and medical factors affect early and late CR enrollment even after receiving CR referral after AMI. Women, the uninsured, and patients with hypertension, peripheral arterial disease, lower physical function, and prior percutaneous coronary intervention are less likely to participate at 1-month while non-Caucasians, older individuals, smokers and individuals with economic burden were less likely to participate at 6-months after AMI. These individuals represent populations at significantly increased cardiovascular risk who may benefit from the more intense secondary prevention services provided in CR. Since CR is associated with beneficial changes in cardiovascular risk factors and better outcomes, more aggressive efforts to increase CR participation after AMI are needed. There are still substantial gender and socio-economic disparities in CR use that will require additional interventions to overcome. While creating a performance measurement for referral is an important first step, creating a second measure to examine actual participation might be a successful adjunct to insure participation if proper denominator specifications can be created. See p 1587.
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study
Biomarkers for predicting cardiovascular events in communitybased populations have not consistently added information to standard risk factors. A limitation of many previously studied biomarkers is their lack of cardiovascular specificity. We examined 3 novel biomarkers induced by cardiovascular stress (soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I) in 3428 participants in the Framingham Heart Study followed up for a mean of 11.3 years. After adjustment for traditional risk factors, the 3 new biomarkers were associated with each end point (PϽ0.001) except coronary events. Individuals with multimarker scores in the highest quartile had a 3-fold risk of death (PϽ0.001), 6-fold risk of heart failure (PϽ0.001), and 2-fold risk of cardiovascular events (Pϭ0.001). Addition of the multimarker score to clinical variables led to significant increases in the c statistic (Pϭ0.005 or lower) and net reclassification improvement (Pϭ0.001 or lower). Our findings support the concept that cardiovascular dysfunction or injury can exist for many years before the onset of overt disease and highlight the prognostic value of biomarkers of cardiovascular stress in apparently healthy individuals. See p 1596.
Should We Emergently Revascularize Occluded Coronaries for Cardiac Arrest? Rapid-Response Extracorporeal Membrane Oxygenation and Intra-Arrest Percutaneous Coronary Intervention
Cardiac arrest is a major cause of unexpected death. Despite cardiopulmonary resuscitation (CPR), only a few patients who suffer cardiac arrest are able to return to their former lifestyles. Extracorporeal CPR, an alternative CPR method in which extracorporeal membrane oxygenation (ECMO) is used, has been reported to be effective for patients in whom conventional CPR cannot achieve the return of spontaneous circulation. Venoarterial ECMO in patients undergoing cardiac arrest provides adequate temporal perfusion to the organs before the return of spontaneous circulation. A high incidence of acute coronary syndrome is reported in cardiac arrest patients, and the use of percutaneous coronary intervention (PCI) in postresuscitation care has recently been noted to improve the outcomes of such patients. We therefore investigated the associations among extracorporeal CPR, intra-arrest PCI, and patient outcomes. In this study, rapid-response ECMO was performed in 86 patients with acute coronary syndrome who were unresponsive to conventional CPR. The study patients were usually thought to have unfavorable prognosis when treated with conventional CPR. However, we obtained encouraging results: 89% of the study patients achieved return of spontaneous heartbeat, 46% were weaned from ECMO, 25% had a 30-day survival, and 19% had favorable neurological findings at the time of hospital discharge. This study showed a definitively higher rate of return of spontaneous heartbeat (100%) and improved outcomes in cardiac arrest patients with acute coronary syndrome treated with ECMO and intra-arrest PCI. PCI is feasible in this setting and can increase return of spontaneous heartbeat and improve outcomes. Randomized studies of intra-arrest PCI based on these findings are needed. See p 1605.
Childhood Air Pollutant Exposure and Carotid Artery Intima-Media Thickness in Young Adults
The atherogenic process has important determinants early in life. Childhood exposure to ozone may be a novel risk factor for carotid artery intima-media thickness in young adults. Exposure to ambient air pollutants increases risk for cardiovascular health outcomes in adults. Early life exposure to ozone has been associated with childhood lung function development. Systemic inflammation induced first in the lung may be propagated throughout the body to target other organ systems. Regulation of air pollutants and efforts We used the Society of Thoracic Surgeons database to examine long-term survival among 145 911 aortic valve replacement patients Ն65 years of age. In-hospital complications and long-term survival were stratified by age, Society of Thoracic Surgeons perioperative risk of mortality, and several comorbidities. We found that long-term survival after surgical aortic valve replacement in the elderly is excellent, although patients with a high Society of Thoracic Surgeons perioperative risk of mortality and those with certain comorbidities (lung disease and renal failure, particularly dialysisdependent renal failure) carry a particularly poor long-term prognosis. Although the current Society of Thoracic Surgeons perioperative risk of mortality calculator provides reasonable differentiation of long-term survival, a model calibrated to the prediction of long-term risk would be expected to add accuracy. We believe our study is significant in that it examines an area in which there are limited data, namely contemporary long-term outcomes after aortic valve replacement in older individuals. We believe that our findings may improve long-term outcomes for this elderly population by helping to establish best practices in operative and perioperative care. See p 1621.
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists: Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates
Periprocedural heparin bridging with low-molecular-weight heparin (LMWH) in patients on long-term warfarin aims to reduce the risk of thromboembolic events in the immediate periprocedural period. However, although periprocedural anticoagulation remains a common clinical problem, optimal methods have not been established. Recently published international guidelines on antithrombotic therapy recommend an individualized approach to determining the need for bridging anticoagulation based on a patient's estimated thromboembolic risk and periprocedural bleed risk. Using established methods, we conducted a systematic review and meta-analysis of 34 studies (including 1 randomized trial) that used low-molecularweight heparin as periprocedural bridging therapy. We used lowthromboembolic-risk groups who did not receive bridging therapy or patients who were not on warfarin for comparators to assess baseline periprocedural thromboembolic and bleed risks. We found a Ͼ5-fold increased risk of overall bleeding and Ͼ3-fold increased risk of major bleeding associated with the use of bridging therapy, with a similar risk of thromboembolism (including arterial thromboembolism) in bridged and nonbridged patients. There was also an increased risk of overall bleeding when full and prophylactic or intermediate doses of low-molecular-weight heparin bridging were compared. In studies that stratified procedural bleed risk, bleed rates were highest in mostly bridged patients undergoing high-bleed-risk procedures. We concluded that patients on long-term warfarin should avoid routine periprocedural bridging with low-molecular-weight heparin, especially patients not at high thromboembolic risk using therapeutic doses of bridging therapy and undergoing high-bleed-risk procedures. Randomized trials are urgently needed to define the role of periprocedural heparin bridging. See p 1630.
